Results 141 to 150 of about 3,871 (249)

5．CKD-MBD

Nihon Toseki Igakkai Zasshi, 2022
openaire   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Allopurinol has no effect on calcitriol or other CKD-MBD biomarkers: a randomized double-blind study. [PDF]

J Endocr Soc
Costa TE, Lauar JC, Innecchi MLR, Araujo LKRP, Coelho VA, Dos Reis LM, Moysés RMA, Elias RM.   +7 more
europepmc   +1 more source

Testing Patterns for CKD-MBD Abnormalities in a Sample US Population. [PDF]

Kidney Int Rep, 2021
Wetmore JB, Ji Y, Ashfaq A, Gilbertson DT, Roetker NS.   +4 more
europepmc   +1 more source

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Tumoral calcinosis complicating CKD-MBD in hemodialysis: a case report. [PDF]

Open Life Sci
Chen C, Wang X, Gao BH.
europepmc   +1 more source

Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce. [PDF]

Pediatr Nephrol, 2023
Bacchetta J, Schmitt CP, Bakkaloglu SA, Cleghorn S, Leifheit-Nestler M, Prytula A, Ranchin B, Schön A, Stabouli S, Van de Walle J, Vidal E, Haffner D, Shroff R.   +12 more
europepmc   +1 more source

Modeling Longitudinal Relationships Between CKD-MBD Biomarker Trajectories with Interpretable Machine Learning in a Large Prospective CKD Cohort. [PDF]

J Clin Med
Taskapan T, Taskapan H, Bellasi A, Mahdavi S, Ma H, Tam P, Sikaneta T.   +6 more
europepmc   +1 more source

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study. [PDF]

Bone Rep, 2021
Vasco RFV, Takayama L, Pereira RMR, Moyses RMA, Elias RM.   +4 more
europepmc   +1 more source

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

FlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu, Yubing Hu, Dong Wang, Ben Zhong Tang   +3 more
wiley   +1 more source